Meningiomas: risk factors
Evidence-based neurology checklist on meningiomas: risk factors: Major tumour syndromes Neurofibromatosis type 2 (NF2) Multiple endocrine neoplasia type 1 (MEN1) Copy number alterations (CNAs) Major cancer predisposition mutations Other cancer predisposition mutations Epigenomic alterations: DNA…
Major tumour syndromes
- Neurofibromatosis type 2 (NF2)
- Multiple endocrine neoplasia type 1 (MEN1)
Copy number alterations (CNAs)
Major cancer predisposition mutations
Other cancer predisposition mutations
Epigenomic alterations: DNA methylation
Epigenomic alterations: micro RNA
Hormonal risk factors
Environmental risk factors
References
- Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010; 99:307-314.
- Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 2015; 122:4-23.
- Nigim F, Wakimoto H, Kasper EM, Ackermans L, Temel Y. Emerging medical treatments for meningioma in the molecular era. Biomedicines 2018; 6(3) pii: E86.
- Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 2013; 118:649-656.
- Suppiah S, Nassiri F, Bi WL, et al; International Consortium on Meningiomas. Molecular and translational advances in meningiomas. Neuro Oncol 2019; 21(Supplement_1):i4-i17.
- And 7 more. Subscribe to see the full list
